Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMC Complementary Medicine and Therapies|January 12, 2022
Effectiveness of maturity of Rubus occidentalis on hyperalgesia induced by acidic saline injection in ratsGeun Joo Choi, Hyun Kang, Oh Haeng Lee, et al.Molecular Biosystems|November 29, 2014
A pre-structured helix in the intrinsically disordered 4EBP1Do-Hyoung Kim, Chewook Lee, Ye-Jin Cho, et al.Angewandte Chemie (International Ed. in English)|December 22, 2016
The Mechanism of p53 Rescue by SUSP4Do-Hyoung Kim, Chewook Lee, Si-Hyung Lee, et al.Biomolecules & Therapeutics|May 14, 2023
Synergistic Renoprotective Effect of Melatonin and Zileuton by Inhibition of Ferroptosis <i>via</i> the AKT/mTOR/NRF2 Signaling in Kidney Injury and FibrosisKyung Hee Jung, Sang Eun Kim, Han Gyeol Go, et al.Biomolecules & Therapeutics|October 1, 2025
Dietary Potassium Synergistically Enhances Anti-Obesity Efficacy of Garcinia Cambogia Complex in High-Fat Diet-Induced Obese MiceEunji Park, Sehan Kwak, Ayoung Lim, et al.International Journal of Molecular Medicine|November 14, 2024
Repositioning of aripiprazole, an anti‑psychotic drug, to sensitize the chemotherapy of pancreatic cancerYe Jin Cho, Beom Seok Han, Soyeon Ko, et al.American Journal of Cancer Research|August 15, 2022
Lidocaine enhances the efficacy of palbociclib in triple-negative breast cancerBeom Seok Han, Kyung Hee Jung, Ji Eun Lee, et al.International Immunopharmacology|September 23, 2024
Lidocaine combined with general anesthetics impedes metastasis of breast cancer cells via inhibition of TGF-β/Smad-mediated EMT signaling by reprogramming tumor-associated macrophagesBeom Seok Han, Soyeon Ko, Min Seok Park, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 22, 2023
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancerJi Eun Lee, Pureunchowon Lee, Young-Chan Yoon, et al.American Journal of Cancer Research|October 13, 2022
A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancerSoyeon Ko, Kyung Hee Jung, Young-Chan Yoon, et al.Pageof 2